Platform
Home
Screener
Copilot
AskEdgar Studio
New
Back
Cerus Corporation
CERS · SEC Filings
website
268
Cerus Corporation operates as a biotechnology firm dedicated to advancing and marketing the INTERCEP...
Price
2.07
Market Cap
418.05 M
Float
195.82 M
Country
US
Sector
Healthcare
Exchange
NASDAQ
Overview
Filings
Insights
Dilution
News
Transcripts
Search in Documents
Open in Studio
Studio
Login
Ask about CERS
TYPE
HEADLINE
FILED AT
TYPE
HEADLINE
FILED AT
TYPE
HEADLINE
FILED AT
TYPE
HEADLINE
FILED AT
All
Chronological
Financials
Registrations
Prospectus
News
Proxies
Ownerships
Other
Cerus Corporation
CERS · SEC Filings
195.82 M
Float
2.07
Price
418.05 M
Market Cap
Financials
TYPE
HEADLINE
FILED AT
10-Q
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 2, 2026
10-Q
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 30, 2026
10-Q
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 30, 2026
10-K
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 2, 2026
10-Q
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 6, 2025
10-Q
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 5, 2025
News
TYPE
HEADLINE
FILED AT
8-K
Cerus Corporation Reports Third Quarter 2026 Financial Results and Positive Phase 3 RedeS Results
Nov 2, 2026
8-K
Cerus Corporation Reports Q2 2026 Financial Results and Raises 2026 Product Revenue Guidance
Jul 30, 2026
8-K
Cerus Corporation Announces Terms of Executive Chairman Agreement for William Greenman
Jul 10, 2026
8-K
Cerus Corporation Enters into Amended and Restated Credit Agreements
Jun 8, 2026
8-K
Cerus Corporation Announces Results of 2026 Annual Meeting of Stockholders
Jun 3, 2026
8-K
Cerus Corporation Reports Q1 2026 Financial Results and Raises Full-Year Product Revenue Guidance
Apr 30, 2026
Prospectus
TYPE
HEADLINE
FILED AT
424B5
Common Stock-
Dec 11, 2020
424B5
14,666,667 Shares
Jan 30, 2020
424B5
Common Stock
Jan 28, 2020
424B5
12,200,000 Shares
Feb 1, 2018
424B5
Common Stock
Jan 30, 2018
424B5
$70,000,000 Common Stock PROSPECTUS January 8, 2018
Jan 8, 2018
Registrations
TYPE
HEADLINE
FILED AT
S-3
November 2026 SHELF
Nov 2, 2026
S-8
Form S-8 - Securities to be offered to employees in employee benefit plans
Jul 30, 2026
S-8
Form S-8 - Securities to be offered to employees in employee benefit plans
Aug 5, 2025
S-8
Registration
Aug 1, 2024
S-8
Registration
Nov 2, 2023
S-3
SHELF | ATM | Offering amount: $150,000,000.00 EFFECTIVE
Nov 2, 2023
Proxies
TYPE
HEADLINE
FILED AT
DEFA14A
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Apr 22, 2026
DEF 14A
Form DEF 14A - Other definitive proxy statements
Apr 22, 2026
DEFA14A
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
May 23, 2025
DEFA14A
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Apr 23, 2025
DEF 14A
Form DEF 14A - Other definitive proxy statements
Apr 23, 2025
DEFA14A
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Apr 26, 2024
Ownerships
TYPE
HEADLINE
FILED AT
S-3
Form S-3 - Registration statement under Securities Act of 1933
Nov 2, 2026
4
Jensen Chrystal (Reporting)
Aug 17, 2026
144
Form 144 - Report of proposed sale of securities
Aug 17, 2026
SCHEDULE 13G/A
BAKER BROS. ADVISORS LP (Filed by)
Aug 14, 2026
SCHEDULE 13G/A
ARK Investment Management LLC (Filed by)
Aug 14, 2026
SCHEDULE 13G/A
Soleus Capital Master Fund, L.P. (Filed by)
Aug 13, 2026
Chronological
TYPE
HEADLINE
FILED AT
Other
TYPE
HEADLINE
FILED AT
SD
Form SD - Specialized disclosure report
May 29, 2026
SD
Form SD - Specialized disclosure report
May 30, 2025
SD
Form SD - Specialized disclosure report
May 31, 2024
EFFECT
Form EFFECT - Notice of Effectiveness
Nov 16, 2023
CORRESP
Form CORRESP - Correspondence
Nov 13, 2023
LETTER
Form UPLOAD - SEC-generated letter
Nov 9, 2023
